Trevi Therapeutics (TRVI) Institutional Ownership $4.05 -0.10 (-2.41%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Trevi Therapeutics (NASDAQ:TRVI)CurrentInstitutional OwnershipPercentage95.76%Number ofInstitutional Buyers(last 12 months)25TotalInstitutional Inflows(last 12 months)$13.69MNumber ofInstitutional Sellers(last 12 months)11TotalInstitutional Outflows(last 12 months)$10.05M Get TRVI Insider Trade Alerts Want to know when executives and insiders are buying or selling Trevi Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TRVI Institutional Buying and Selling by Quarter Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Trevi Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/19/2024 Barclays PLC95,232$319K0.0%+180.8%0.124% 11/16/2024 Geode Capital Management LLC1,264,166$4.22M0.0%+10.2%1.645% 11/15/2024 Barclays PLC95,232$319K0.0%+180.8%0.124% 11/15/2024 Jane Street Group LLC32,929$110K0.0%-50.4%0.043% 11/15/2024 State Street Corp952,912$3.18M0.0%+5.9%1.240% 11/15/2024 Checkpoint Capital L.P.250,000$835K0.4%-50.0%0.325% Get the Latest News and Ratings for TRVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Trevi Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/14/2024 Fred Alger Management LLC76,544$256K0.0%N/A0.100% 11/14/2024 Ally Bridge Group NY LLC1,322,800$4.42M2.4%-10.3%1.721% 11/14/2024 Acuta Capital Partners LLC290,500$970K0.8%+11.7%0.378% 11/13/2024 BNP Paribas Financial Markets11,930$40K0.0%+130.9%0.016% 11/9/2024 Landscape Capital Management L.L.C.424,725$1.42M0.1%-29.8%0.585% 11/9/2024 Intech Investment Management LLC18,914$63K0.0%N/A0.026% 11/7/2024 MAI Capital Management1,327,285$4.43M0.0%+0.7%1.828% 11/6/2024 Oppenheimer & Co. Inc.81,947$274K0.0%+34.7%0.113% 11/5/2024 GSA Capital Partners LLP122,447$409K0.0%N/A0.169% 10/30/2024 Rosalind Advisors Inc.750,000$2.51M1.6%-46.1%1.033% 10/3/2024 SG Americas Securities LLC23,405$78K0.0%N/A0.033% 8/15/2024 The Manufacturers Life Insurance Company24,524$73K0.0%+87.6%0.035% 8/14/2024 Logos Global Management LP2,800,000$8.34M0.7%+27.3%3.975% 8/14/2024 Ally Bridge Group NY LLC1,474,926$4.40M2.6%N/A2.094% 8/13/2024 Rubric Capital Management LP5,026,931$14.98M0.4%-9.7%7.137% 8/12/2024 Hsbc Holdings PLC19,612$61K0.0%N/A0.028% 8/9/2024 Renaissance Technologies LLC51,900$155K0.0%-55.6%0.074% 8/9/2024 Dimensional Fund Advisors LP72,210$215K0.0%+217.6%0.103% 8/8/2024 American Century Companies Inc.54,108$161K0.0%+17.1%0.077% 8/1/2024 Rhumbline Advisers75,218$224K0.0%+44.8%0.107% 7/26/2024 Bank of New York Mellon Corp178,511$532K0.0%+38.8%0.253% 7/12/2024 Rosalind Advisors Inc.1,391,577$4.15M3.0%+50.3%1.976% 5/29/2024 Opaleye Management Inc.2,645,000$9.13M2.0%+4.3%3.756% 5/15/2024 Price T Rowe Associates Inc. MD13,561$47K0.0%N/A0.019% 5/14/2024 Propel Bio Management LLC260,000$897K0.5%N/A0.369% 5/10/2024 Vanguard Group Inc.2,303,648$7.95M0.0%+2.7%3.271% 5/7/2024 Oppenheimer & Co. Inc.60,415$208K0.0%N/A0.086% 5/7/2024 SG Americas Securities LLC14,592$50K0.0%-85.1%0.021% 5/1/2024 BNP Paribas Financial Markets20,577$71K0.0%-84.4%0.030% 4/25/2024 Rosalind Advisors Inc.926,016$3.20M3.0%-50.3%1.343% 2/15/2024 Opaleye Management Inc.2,535,000$3.40M0.9%+48.6%3.970% 2/15/2024 Frazier Life Sciences Management L.P.7,381,090$9.89M0.5%+7.3%11.559% 2/5/2024 WealthTrust Axiom LLC63,500$85K0.0%-32.1%0.099% 1/12/2024 SG Americas Securities LLC98,253$132K0.0%+401.4%0.154% Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong (Ad)Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself.1/4/2024 Trust Co. of Toledo NA OH36,502$49K0.0%-68.8%0.057% 11/13/2023 Silverarc Capital Management LLC927,415$2.02M0.6%+4.7%1.452% 10/20/2023 Trust Co. of Toledo NA OH117,145$255K0.1%-6.2%0.183% 10/13/2023 SG Americas Securities LLC19,597$43K0.0%N/A0.031% 9/21/2023 Barclays PLC14,052$34K0.0%N/A0.022% 8/11/2023 VR Adviser LLC3,422,397$8.18M1.3%+12.2%5.697% 8/11/2023 Tejara Capital Ltd180,227$431K0.2%-5.3%0.300% 8/4/2023 American International Group Inc.20,037$48K0.0%N/A0.033% 8/3/2023Innovis Asset Management LLC43,232$103K0.0%-50.5%0.072% 8/2/2023 MAI Capital Management1,534,652$3.67M0.1%-4.1%2.555% 7/10/2023 Trust Co. of Toledo NA OH124,857$298K0.1%+50.4%0.208% 5/12/2023 Tejara Capital Ltd190,218$352K0.2%+26.8%0.317% 5/10/2023 MAI Capital Management1,600,415$2.96M0.0%-7.0%2.664% 4/4/2023 Trust Co. of Toledo NA OH83,000$154K0.0%N/A0.138% 2/10/2023 Opaleye Management Inc.485,000$936K0.3%N/A0.809% 2/9/2023 MAI Capital Management1,720,676$3.32M0.1%-14.8%2.872% 2/3/2023 Frazier Life Sciences Management L.P.6,663,590$12.86M0.8%+23.3%11.121% 2/2/2023 Bailard Inc.21,200$41K0.0%N/A0.035% 2/1/2023 Bank of Montreal Can152,300$294K0.0%N/A0.254% 11/15/2022 TPG GP A LLC251,780$388K0.0%-94.2%0.571% 11/14/2022 Armistice Capital LLC864,000$1.33M0.0%+107.7%1.961% 11/14/2022 Altium Capital Management LP1,066,157$1.64M0.6%-17.0%2.419% 11/14/2022 Rubric Capital Management LP5,684,420$8.75M0.4%+219.6%12.899% 11/10/2022 Hillsdale Investment Management Inc.86,531$133K0.0%N/A0.196% 11/9/2022 Fairmount Funds Management LLC5,696,515$8.77M1.5%+250.7%12.926% 11/7/2022 Jump Financial LLC42,977$66K0.0%N/A0.098% 10/28/2022 Silverarc Capital Management LLC939,265$1.45M0.5%N/A2.131% 8/15/2022 Acuta Capital Partners LLC35,000$98K0.1%N/A0.090% 8/10/2022 Frazier Life Sciences Management L.P.1,171,627$3.29M0.3%N/A3.029% 7/27/2022 WealthTrust Axiom LLC93,500$262K0.1%-5.1%0.242% 7/19/2022 MAI Capital Management2,040,009$5.73M0.1%+32.3%5.273% 5/10/2022 MAI Capital Management1,541,471$3.39M0.1%N/A3.985% 5/9/2022 WealthTrust Axiom LLC98,500$216K0.1%+245.6%0.255% 5/4/2022Commonwealth Equity Services LLC15,000$33K0.0%N/A0.049% 8/17/2021 Bridgeway Capital Management LLC34,600$78K0.0%-68.4%0.160% 8/16/2021 Alberta Investment Management Corp25,000$56K0.0%N/A0.116% 8/13/2021 Renaissance Technologies LLC92,600$208K0.0%-24.0%0.429% 5/21/2021 Citadel Advisors LLC10,617$29K0.0%N/A0.053% 5/18/2021 Citadel Advisors LLC10,617$29K0.0%N/A0.053% 5/13/2021 Renaissance Technologies LLC121,849$330K0.0%+374.1%0.611% 5/7/2021BlackRock Inc.32,394$87K0.0%+40.6%0.163% 4/14/2021 WealthTrust Axiom LLC38,500$104K0.0%+234.8%0.193% 3/26/2021 Susquehanna International Group LLP14,828$36K0.0%N/A0.081% 2/17/2021 Canada Pension Plan Investment Board15,000$36K0.0%N/A0.082% 2/10/2021 Renaissance Technologies LLC25,700$62K0.0%N/A0.140% 2/4/2021 WealthTrust Axiom LLC11,500$27K0.0%N/A0.063% (Data available from 1/1/2016 forward) TRVI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TRVI shares? During the previous two years, 39 institutional investors and hedge funds held shares of Trevi Therapeutics. The most heavily invested institutionals were Rubric Capital Management LP ($14.98M), Frazier Life Sciences Management L.P. ($9.89M), Opaleye Management Inc. ($9.13M), Logos Global Management LP ($8.34M), VR Adviser LLC ($8.18M), Vanguard Group Inc. ($7.95M), and MAI Capital Management ($4.43M).Learn more on TRVI's institutional investors. What percentage of Trevi Therapeutics stock is owned by institutional investors? 95.76% of Trevi Therapeutics stock is owned by institutional investors. Learn more on TRVI's institutional investor holdings. Which institutional investors have been buying Trevi Therapeutics stock? Of the 32 institutional investors that purchased Trevi Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Frazier Life Sciences Management L.P. ($1.76M), Ally Bridge Group NY LLC ($1.47M), Opaleye Management Inc. ($1.42M), Logos Global Management LP ($600K), Rosalind Advisors Inc. ($465.56K), VR Adviser LLC ($372.38K), and Propel Bio Management LLC ($260K). How much institutional buying is happening at Trevi Therapeutics? Institutional investors have bought a total of 7,766,817 shares in the last 24 months. This purchase volume represents approximately $18.82M in transactions. Which Trevi Therapeutics major shareholders have been selling company stock? Of the 14 institutional investors that sold Trevi Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Rosalind Advisors Inc. ($1.58M), Rubric Capital Management LP ($537.19K), MAI Capital Management ($484.51K), Checkpoint Capital L.P. ($250.09K), Landscape Capital Management L.L.C. ($180.72K), Ally Bridge Group NY LLC ($152.13K), and BNP Paribas Financial Markets ($111.63K). How much institutional selling is happening at Trevi Therapeutics? Institutional investors have sold a total of 3,648,779 shares in the last 24 months. This volume of shares sold represents approximately $11.15M in transactions. Related Companies ARVN Major Shareholders DAWN Major Shareholders ARDX Major Shareholders SYRE Major Shareholders CALT Major Shareholders SPRY Major Shareholders ANIP Major Shareholders SNDX Major Shareholders RCKT Major Shareholders BCYC Major Shareholders This page (NASDAQ:TRVI) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trevi Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Trevi Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
